240 related articles for article (PubMed ID: 33746066)
1. Structure and activation mechanism of the human liver-type glutaminase GLS2.
Ferreira IM; Quesñay JEN; Bastos AC; Rodrigues CT; Vollmar M; Krojer T; Strain-Damerell C; Burgess-Brown NA; von Delft F; Yue WW; Dias SM; Ambrosio AL
Biochimie; 2021 Jun; 185():96-104. PubMed ID: 33746066
[TBL] [Abstract][Full Text] [Related]
2. Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer.
Lukey MJ; Cluntun AA; Katt WP; Lin MJ; Druso JE; Ramachandran S; Erickson JW; Le HH; Wang ZE; Blank B; Greene KS; Cerione RA
Cell Rep; 2019 Oct; 29(1):76-88.e7. PubMed ID: 31577957
[TBL] [Abstract][Full Text] [Related]
3. A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis.
Katt WP; Lukey MJ; Cerione RA
Future Med Chem; 2017 Jan; 9(2):223-243. PubMed ID: 28111979
[TBL] [Abstract][Full Text] [Related]
4. GLS2 is protumorigenic in breast cancers.
Dias MM; Adamoski D; Dos Reis LM; Ascenção CFR; de Oliveira KRS; Mafra ACP; da Silva Bastos AC; Quintero M; de G Cassago C; Ferreira IM; Fidelis CHV; Rocco SA; Bajgelman MC; Stine Z; Berindan-Neagoe I; Calin GA; Ambrosio ALB; Dias SMG
Oncogene; 2020 Jan; 39(3):690-702. PubMed ID: 31541193
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Basis of Glutaminase Activation: A KEY ENZYME THAT PROMOTES GLUTAMINE METABOLISM IN CANCER CELLS.
Li Y; Erickson JW; Stalnecker CA; Katt WP; Huang Q; Cerione RA; Ramachandran S
J Biol Chem; 2016 Sep; 291(40):20900-20910. PubMed ID: 27542409
[TBL] [Abstract][Full Text] [Related]
6. Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.
Martín-Rufián M; Nascimento-Gomes R; Higuero A; Crisma AR; Campos-Sandoval JA; Gómez-García MC; Cardona C; Cheng T; Lobo C; Segura JA; Alonso FJ; Szeliga M; Albrecht J; Curi R; Márquez J; Colquhoun A; Deberardinis RJ; Matés JM
J Mol Med (Berl); 2014 Mar; 92(3):277-90. PubMed ID: 24276018
[TBL] [Abstract][Full Text] [Related]
7. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
[TBL] [Abstract][Full Text] [Related]
8. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.
Lee YZ; Yang CW; Chang HY; Hsu HY; Chen IS; Chang HS; Lee CH; Lee JC; Kumar CR; Qiu YQ; Chao YS; Lee SJ
Oncotarget; 2014 Aug; 5(15):6087-101. PubMed ID: 25026281
[TBL] [Abstract][Full Text] [Related]
9. The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled.
Li Y; Ramachandran S; Nguyen TT; Stalnecker CA; Cerione RA; Erickson JW
J Biol Chem; 2020 Jan; 295(5):1328-1337. PubMed ID: 31871054
[TBL] [Abstract][Full Text] [Related]
10. Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis.
Zhang C; Liu J; Zhao Y; Yue X; Zhu Y; Wang X; Wu H; Blanco F; Li S; Bhanot G; Haffty BG; Hu W; Feng Z
Elife; 2016 Jan; 5():e10727. PubMed ID: 26751560
[TBL] [Abstract][Full Text] [Related]
11. Two Faces of Glutaminase GLS2 in Carcinogenesis.
Buczkowska J; Szeliga M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067269
[TBL] [Abstract][Full Text] [Related]
12. Expression of Gls and Gls2 glutaminase isoforms in astrocytes.
Cardona C; Sánchez-Mejías E; Dávila JC; Martín-Rufián M; Campos-Sandoval JA; Vitorica J; Alonso FJ; Matés JM; Segura JA; Norenberg MD; Rama Rao KV; Jayakumar AR; Gutiérrez A; Márquez J
Glia; 2015 Mar; 63(3):365-82. PubMed ID: 25297978
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of glutaminase activation through filamentation and the role of filaments in mitophagy protection.
Adamoski D; Dias MM; Quesñay JEN; Yang Z; Zagoriy I; Steyer AM; Rodrigues CT; da Silva Bastos AC; da Silva BN; Costa RKE; de Abreu FMO; Islam Z; Cassago A; van Heel MG; Consonni SR; Mattei S; Mahamid J; Portugal RV; Ambrosio ALB; Dias SMG
Nat Struct Mol Biol; 2023 Dec; 30(12):1902-1912. PubMed ID: 37857822
[TBL] [Abstract][Full Text] [Related]
14. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.
Suzuki S; Tanaka T; Poyurovsky MV; Nagano H; Mayama T; Ohkubo S; Lokshin M; Hosokawa H; Nakayama T; Suzuki Y; Sugano S; Sato E; Nagao T; Yokote K; Tatsuno I; Prives C
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7461-6. PubMed ID: 20351271
[TBL] [Abstract][Full Text] [Related]
15. High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate binding.
Nguyen TT; Ramachandran S; Hill MJ; Cerione RA
J Biol Chem; 2022 Feb; 298(2):101564. PubMed ID: 34999118
[TBL] [Abstract][Full Text] [Related]
16. Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.
Szeliga M; Albrecht J
Neurochem Int; 2015 Sep; 88():6-9. PubMed ID: 25529918
[TBL] [Abstract][Full Text] [Related]
17. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation.
Velletri T; Romeo F; Tucci P; Peschiaroli A; Annicchiarico-Petruzzelli M; Niklison-Chirou MV; Amelio I; Knight RA; Mak TW; Melino G; Agostini M
Cell Cycle; 2013 Nov; 12(22):3564-73. PubMed ID: 24121663
[TBL] [Abstract][Full Text] [Related]
18. Glutaminase isoenzymes in the metabolic therapy of cancer.
Matés JM; Campos-Sandoval JA; Márquez J
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):158-164. PubMed ID: 30053497
[TBL] [Abstract][Full Text] [Related]
19. Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer.
Saha SK; Islam SMR; Abdullah-Al-Wadud M; Islam S; Ali F; Park KS
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30871151
[TBL] [Abstract][Full Text] [Related]
20. The role of glutaminase in cancer.
Masisi BK; El Ansari R; Alfarsi L; Rakha EA; Green AR; Craze ML
Histopathology; 2020 Mar; 76(4):498-508. PubMed ID: 31596504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]